Elia Marc 4

What Happened
Elia Marc, a director of Fractyl Health, received a grant of 22,500 stock options on June 10, 2026. The grant is reported as a derivative acquisition at $0.00 (no cash paid by the insider). This was a compensation award under the company's non‑employee director policy, not a market purchase or sale.

Key Details

• Transaction date: 2026-06-10; Form 4 filed 2026-06-11 (timely filing).
• Transaction type: Award/Grant (derivative) of 22,500 shares; reported price $0.00.
• Vesting: Options vest and become exercisable in a single installment on the earlier of (i) the next annual meeting of stockholders or (ii) the first anniversary of the grant, subject to continued board service.
• Shares owned after transaction: Not specified in the filing.
• Footnote: Award made pursuant to the issuer's non-employee director compensation policy.

Context
This is a routine director compensation grant (stock option award). It does not represent an immediate purchase or sale of common stock; value depends on future vesting and any exercise price or future stock performance. Such awards are common for non‑employee directors and are primarily compensation, not a direct signal of buying or selling intent.